To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
European Assisted Conception ConsortiumThe European Assisted Conception Consortium or EACC wants to bring together national ART regulators and practitioners within the European Union for professional cooperation and joint action. See also |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "European_Assisted_Conception_Consortium". A list of authors is available in Wikipedia. |
Last viewed
- The changing marketplace of antithrombotics: better than cheaper? - Next generation anticoagulant and antiplatelet agents have shown superiority over the current market leaders in clinical studies and are to challenge them before generics
- The third generation of TPO mimetics are again biologics - After failure of 1st generation thrombopoietic growth factors due to immunogencity, the 2nd generation is focused on oral TPO mimetics, now followed by a 3rd generation of engineered biologics with potential for higher potency and efficacy
